1. Onodera, Atsushi, Kokubo, Kota, Okano, Mikiko, Nakayama, Toshinori, Hirahara, Kiyoshi. 2023. Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases. In Pharmacology & therapeutics, 247, 108445. doi:10.1016/j.pharmthera.2023.108445. https://pubmed.ncbi.nlm.nih.gov/37201737/
2. Wu, Song, Li, Zongdong, Gnatenko, Dmitri V, Nesbitt, Natasha M, Bahou, Wadie F. 2016. BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans. In Blood, 128, 699-709. doi:10.1182/blood-2016-02-696997. https://pubmed.ncbi.nlm.nih.gov/27207795/
3. Li, Zongdong, Nesbitt, Natasha M, Malone, Lisa E, Girnun, Geoffrey D, Bahou, Wadie F. 2018. Heme degradation enzyme biliverdin IXβ reductase is required for stem cell glutamine metabolism. In The Biochemical journal, 475, 1211-1223. doi:10.1042/BCJ20180016. https://pubmed.ncbi.nlm.nih.gov/29500232/
4. Huan, Lin, Bao, Chunyang, Chen, Di, Liang, Linhui, He, Xianghuo. 2016. MicroRNA-127-5p targets the biliverdin reductase B/nuclear factor-κB pathway to suppress cell growth in hepatocellular carcinoma cells. In Cancer science, 107, 258-66. doi:10.1111/cas.12869. https://pubmed.ncbi.nlm.nih.gov/26708147/
智鼠故事 
